New progress in the treatment of primary biliary cholangitis combined with osteoporosis / 中国综合临床

ABSTRACT

Primary biliary cholangitis (PBC), also known as primary biliary cirrhosis, is an autoimmune-mediated chronic intrahepatic cholestatic disease, which is more common in middle-aged and elderly women. Cholestasis can be secondary to hepatic osteodystrophy, with osteoporosis (OP) being the most prominent. OP in PBC patients can increase the risk of fracture and seriously affect the survival and quality of life of patients, thus affecting the prognosis of the disease. In recent years, a large number of studies have shown that with the increase of the incidence and prevalence of PBC, the incidence and prevalence of OP are also on the rise. Therefore, in order to improve the survival and quality of life of patients with PBC combined with OP, how to effectively treat it has become the focus of more and more attention and research.